跳至主要内容
临床试验/NCT05365074
NCT05365074已完成不适用

Perioperative Outcomes in Patients Received Spinal Chloroprocaine for Hip or Knee Arthroplasty

Hôpital de la Croix-Rousse1 个研究点 分布在 1 个国家目标入组 65 人开始时间: 2020年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
65
试验地点
1
主要终点
Spinal anesthesia failure

研究概览

简要总结

This study evaluates the perioperative course in adult patients undergoing total or partial knee arthroplasty, or total hip arthroplasty under chloroprocaine spinal anesthesia.

详细描述

This study evaluates the failure rate of spinal anesthesia, the duration of surgical anesthesia, the needs for complementary intraoperative analgesia, the time for recovery, the incidence of urinary retention, postoperative nausea and vomiting, and length of stay in the recovery room in patients operated for knee or hip arthroplasty under spinal anesthesia with chloroprocaine 50 mg.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

接受健康志愿者

入选标准

  • adult patients
  • with spinal anesthesia using 50 mg of chloroprocaine
  • operated for total knee, unicompartment knee or anterior access hip arthroplasty
  • in the period of years 2020 - 2021

排除标准

  • expressed disagreement to to participate after receiving information notice

研究组 & 干预措施

chloroprocaine anesthesia for arthroplasty

patients having predicted uncomplicated surgery for total or unicompartment knee arthroplasty of anterior access total hip arthroplasty, operated under spinal anesthesia with 50 mg of chloroprocaine

干预措施: Chloroprocaine Injection (Drug)

结局指标

主要结局

Spinal anesthesia failure

时间窗: Day 0

proportion of patients with the necessity to convert initially planned spinal anesthesia into general anesthesia

次要结局

  • Urinary retention(24 hours)
  • Postoperative nausea and vomiting(24 hours)
  • Need for sedation(Day 0)
  • Surgical block duration(Day 0)
  • PACU analgesia requirement(Day 0)
  • Hemodynamic instability(Day 0)
  • Length of stay in recovery room(Day 0)

研究者

发起方
Hôpital de la Croix-Rousse
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mikhail Dziadzko, MD, PhD

Senior physician

Hôpital de la Croix-Rousse

研究点 (1)

Loading locations...

相似试验